Product Description

Product name
| AF710B |
Cas NO.
| 1235733-73-9 |
Purity
| 99%
|
Appearance
| White Powder |
Molecular Formula
| C20H27N3OS |
| Molecular Weight | 357.5 |
| Synonyms | ANAVEX 3-71; AF-710B; AF 710B; AAE07Z061B |
| Shelf life | 2 Years |
AF710B (CAS 1235733-73-9, C₂₀H₂₇N₃OS, MW 357.5), also known as ANAVEX 3-71, is a spiro-indole small molecule and a dual-target ligand acting as an allosteric agonist at the M1 muscarinic acetylcholine receptor (M1 mAChR) and an agonist at the sigma-1 (σ1) receptor. The M1 receptor is a principal mediator of cholinergic signaling in the cortex and hippocampus, while the σ1 receptor is a chaperone protein at the mitochondria-associated endoplasmic reticulum membrane (MAM) involved in cellular stress responses. AF710B is distinctive in engaging both targets simultaneously: it allosterically potentiates endogenous acetylcholine signaling at M1 rather than directly activating the orthosteric site. Published preclinical work reports that its effects on amyloid pathology, synaptic markers and cognitive performance depend on activation of both targets together rather than either alone. It is primarily used as a preclinical research tool in Alzheimer's disease and related neurodegenerative research.
Mechanism of Action
AF710B is a dual-target compound combining allosteric agonist activity at the M1 muscarinic acetylcholine receptor with agonist activity at the σ1 receptor. At M1, it acts allosterically: it does not compete with acetylcholine at the orthosteric site, preserving physiological ACh signaling, thereby enhancing cholinergic transmission while avoiding the receptor desensitization and narrow therapeutic window typical of conventional orthosteric M1 agonists. At σ1, it acts as an agonist, modulating cellular stress responses, neuroprotection and neurotransmitter systems. M1 receptors mediate cholinergic transmission in the cortex and hippocampus and are closely linked to cognition, whereas σ1 receptors participate in neuroprotection and modulation of glutamatergic and other signaling. Fisher et al. (2016) reported that AF710B's cognitive improvement and pathology reduction in Alzheimer's disease animal models depend on the combined activation of both M1 and σ1 targets, and that engaging either target alone is insufficient to reproduce its effects. In vivo, its effects involve amyloid and tau pathology, neuroinflammation and synaptic dysfunction.
Function&Application
Dual-target receptor pharmacology: studies of combined M1 allosteric modulation and σ1 agonism
Amyloid pathology models: plaque and related marker studies in transgenic mouse/rat models of Alzheimer-like pathology
Synaptic and neuroinflammatory research: synaptic spine density, glial markers and related readouts
Cognitive behavioral assays: scopolamine reversal and transgenic-model cognitive tasks
Disease-modification research: evaluation of effects persisting after washout
Cholinergic signaling: allosteric potentiation preserving physiological ACh signaling
Comparative pharmacology: mechanism comparison with orthosteric M1 agonists and σ1-selective ligands
Analytical reference material: reference standard for chromatographic and mass-spectrometric identification and method development
Key Features
Unique dual-target mechanism: combines M1 allosteric agonism with σ1 agonism; published work indicates both are required for the full downstream effects.
M1 allosteric advantage: does not compete at the orthosteric acetylcholine site, preserving physiological ACh signaling and distinguishing it from desensitizing orthosteric M1 agonists.
Multi-pathology coverage: engages amyloid, tau, neuroinflammation and synaptic dysfunction in preclinical models.
Long-lasting effects: effects reported to persist after washout, supporting disease-modification research.
Well-characterized and quality-controlled: CAS 1235733-73-9 corresponds to PubChem CID 58516166 with complete InChI Key and SMILES records and lot-specific COA.
Package

A variety of standard fixed packaging specifications are available, including aluminum foil zipper bags,sealed aluminum foil bags, aluminum cans and thickened cartons. It fully adapts to different purchasingscenarios such as sample testing, small-batch procurement and large-batch bulk orders. All packagesadopt high-seal and moisture-proof materials, which can effectively isolate air, moisture and impurities,fully ensuring stable product quality during long-term storage, cross-border transportation and transshipment, and avoiding moisture, deterioration and caking.
Shipping

We have a mature and complete global logistics distribution system with diversified shipping channels.Mainstream international couriers such as DHL, FedEx, UPS, EMS and TNT are available, as well asinternational air freight and sea freight for bulk cargo. Goods can be safely delivered to most countries andregions around the world. We will accurately match the most efficient and cost-effective exclusivetransportation solution according to the order weight, cargo volume, expected delivery time anddestination to ensure safe and on-time delivery of goods.
Accept the shipping method specified by the customer.
And We can also recomend you the best shipping method to let you receive the products more safely and faster.
About Knowlux
Knowlux Biotechnology is a GMP-oriented manufacturer and supplier of peptides, APIs and fine-chemical research compounds, operating from Hubei, China. We serve research groups, CDMOs and distributors in more than 40 countries, and support contract synthesis, custom packaging and technical documentation requests.
